Tulip Lab Private Limited - Due diligence report
A 360° intelligence report on Tuliplab: trust score, financial health, credit view, compliance, directors, growth and distress signals - gen…
- Unlock all financial figures & 5-year trends
- Full trust, health & credit-risk scores
- Director details, charges & MCA documents
- One credit unlocks this full due-diligence report
- Use across any company’s report, anytime
- Credits valid for 12 months
Tuliplab — 360° Intelligence Report
Generated from MCA filings & public recordsTuliplab is assessed as Moderate with a Trust Score of 60/100. Tuliplab is an active private limited indian non-government company incorporated in 2004, operating in the Pharma sector. The company has shown revenue growth across its recent filed years. It reported a loss in its latest filed year. Based on MCA filings and public records, it currently shows a moderate compliance risk and high financial risk profile.
Report generated on 05 Aug 2026 from the latest processed filings. Tulip Lab Private Limited snapshot & full profile →
Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.
Score Card
Higher is safer · rule-based & explainableFinancial Intelligence Dashboard
Standalone · 5 filed year(s)Unlock the full 5-year financial dashboard with charts and year-wise figures.
Get full accessScores and observations on this page are already computed from the real filings - only the underlying figures are locked.
Credit & Compliance Intelligence
Why the scores are what they are- Negative operating earnings - debt service depends on external support.
- Working-capital cover adequate.
Charges position: 3 open (39.64 cr) · 8 satisfied (212.53 cr).
| Lender | Charges | Amount |
|---|---|---|
| Others | 4 | 48.0 cr |
| Idbi Trusteeship Services Limited | 1 | 48.0 cr |
| Hdfc Bank Limited | 5 | 48.0 cr |
| State Bank Of India | 1 | 48.0 cr |
- Company status is Active as per MCA.
- Last balance sheet is for Mar 2023 - filings overdue.
- Litigation present in 1 court forum(s).
- Delayed payments to MSME suppliers disclosed (17 disclosure(s)).
- 1 active GST registration(s).
Director Intelligence
Stability score: 95/100| Name | DIN / PAN | Designation | Appointed | Tenure | DIN status |
|---|---|---|---|---|---|
| TUSHAR KUMAR | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| RAJNI RAHUL PANDEY | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| PRASHANT SINGH | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
- 3 directors on the board.
- No disqualified or deactivated DINs.
- Stable board - no exits in 3 years.
- Average tenure above 5 years.
| Name | Designation | Total remuneration |
|---|---|---|
| A K Sharma | Managing Director | 2.4 cr |
| R Mehta | Whole-time Director | 1.6 cr |
| S Iyer | CFO | 95.0 L |
Remuneration is disclosed in the latest annual return. Unlock full report
Ownership & Group Intelligence
As per FY 2022 annual returnPromoters hold a dominant controlling stake - exact percentages are part of the full report.
| Group entity | Relationship | % held |
|---|---|---|
| Chiron International Private Limited | Subsidiary Company | 74.00% |
Full shareholding pattern, group structure & capital events →
Risk Intelligence Center
Growth 90 · Distress 35Stakeholder Verdicts
Vendor · Banker · Investor- Check the compliance flags before onboarding.
- 4 distress signal(s) - see Risk Center.
- Financial filings available for verification.
- Debt capacity assessed from filed statements.
- 3 open charge(s) of 39.64 cr already registered.
- Compliance gaps should be priced into terms.
- 4 growth signal(s) detected.
- Margin and return trends computable from filings.
- Management team looks stable.
MCA Filings & Events Timeline
Latest 15 eventsKey Observations
Auto-generated from the data above| Company | CIN | Location |
|---|---|---|
| Cureworth Drugs & Intermediates | U24232MH2010PTC204157 | Panvel, Maharashtra, India |
| Ever Health Life Sciences Private Limited | U24233AP2008PTC059985 | Vijayawada, Andhra Pradesh, India |
| Sbl Colortech P Ltd | U24220MH1993PTC075266 | Mumbai, Maharashtra, India |
| Machhar Polymer Private Limited | U25200MH1996PTC097211 | Aurangabad, Maharashtra, India |
| Coco Carbons (India) Private Limited | U24200KA2008PTC045966 | Nelamangala Taluk, Karnataka, India |
| Jiwan Metafins Limited | U65921PB1996PLC018501 | Ludhiana, Punjab, India |
| Future Chem Pro Private Limited | U24233MH2016PTC272058 | Thane, Maharashtra, India |
| Albin Polychem Private Limited | U25199DL2012PTC234244 | Delhi, Delhi, India |
Who Uses This Report
CA · CS · Banker · Investor · VendorVerify Tuliplab before audits and certifications: compliance score 60/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.
Track statutory health of Tuliplab: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.
Current banker verdict: Enhanced diligence advised. Credit risk score 45/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.
Investor view: Mixed indicators. Growth score 90/100, margin trends, ownership structure and peer set for Tuliplab - screening before a deeper diligence.
Vendor verdict: Review suggested. Trust score 60/100, distress signals and MSME payment-delay disclosures - know whether Tuliplab pays its suppliers before you extend credit terms.
Litigation footprint (1 case(s) on record), regulatory flags, charge documents trail and director networks for Tuliplab - groundwork for KYC, onboarding and disputes.
Frequently Asked Questions
Is Tuliplab an active company?
Tuliplab has MCA status “Active” with a compliance score of 60/100 (Moderate).
Is Tuliplab financially healthy?
Tuliplab has a Financial Health Score of 30/100 (Caution Indicated) based on its filed financial statements.
Should I do business with Tuliplab?
Its overall Trust Score is 60/100 (Moderate). Vendor verdict: Review suggested. Review the risk flags in the Risk Intelligence Center before deciding.
Who controls Tuliplab?
Promoters hold a dominant controlling stake - exact percentages are in the full report. 3 active director(s) are on record.
Does Tuliplab have loans or charges against its assets?
3 open charge(s) are registered against its assets, and 8 earlier charge(s) stand satisfied.
Is Tuliplab up to date with its ROC filings?
Last balance sheet is for Mar 2023 - filings overdue. Overall compliance score: 60/100 (Moderate).
Is it risky to lend to Tuliplab?
Its Credit Risk Score is 45/100 (Caution Indicated). Banker verdict: Enhanced diligence advised.